GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR5A, HTR6, HTR7 |
16.2964 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR5A, HTR7 |
16.0196 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR5A, HTR7 |
15.9975 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.654 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.6969 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, F2, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MET, MIF, PPARA, PRKCD, SLC1A1, SRC, XDH |
12.1392 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, AXL, CA1, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PRKCD, SIGMAR1, SRC |
10.5825 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
10.5825 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
10.5825 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, GRM5, HTR2A, HTR2B |
10.5101 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
10.5101 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
10.5101 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, ADRB1, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
9.77811 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
9.66667 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A |
9.30929 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A |
9.30929 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM3, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, SRC |
9.19394 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, PPARA, PRKCD, SRC, TYR |
9.02787 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, GRM1, GRM3, GRM5, GRM8, HTR2A |
9.02787 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, ADRB1, AXL, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
9.01508 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MET, MIF, MMP9, PRKCD, SRC, XDH |
9.01508 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, ADRB1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, ESR1, F2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
9.01508 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MET, MIF, MMP9, PRKCD, SRC, XDH |
8.98501 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM3, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
8.9687 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM3, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
8.9687 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM3, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
8.67794 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM3, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
8.65096 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MIF, MMP9, PRKCD, SRC, XDH |
8.56601 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, AXL, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HTR5A, IGF1R, KDR, MMP2, PPARA, PRKCD, SRC, TYR |
8.55449 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA, SLC1A1 |
8.51735 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MIF, MMP9, PRKCD, SRC, XDH |
8.42125 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, F2, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MIF, MMP2, MMP9, PIM1, SRC, XDH |
8.38317 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, AXL, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, PPARA, PRKCD, SRC, TYR |
8.31962 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, ADRB1, AKR1B1, ALOX5, AXL, CACNA1C, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRB, F2, F3, FABP4, GRM1, GRM5, GRM8, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SRC, TYR |
8.29769 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM5, DRD1, DRD2, DRD3, FABP3, GRIA2, GRIA4, GRIK5, HTR2A, HTR2B, PPARA, SLC1A1 |
8.19151 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM3, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, SRC |
7.96029 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, F2, HTR2A, HTR2B, KDR, SRC |
7.89386 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRB1, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, ESRRB, F2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, IGF1R, KDR, MIF, MMP9, PPARA, PRKCD, SRC, XDH |
7.82084 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HTR2A, HTR2B, MET, SRC |
7.82084 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRB1, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, ESRRB, F2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, IGF1R, KDR, MIF, MMP9, PPARA, PRKCD, SRC, XDH |
7.74651 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MIF, MMP9, PRKCD, SRC, XDH |
7.37199 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CYP1B1, DRD2, EGFR, ERBB2, F2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MET, MIF, SRC, XDH |
7.34558 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CHRM1, CSNK2A1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MIF, MMP2, MMP9, PIM1 |
7.2566 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA, SLC1A1 |
6.94264 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.9222 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.9222 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.9222 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MET, MIF, MMP9, PRKCD, SRC, XDH |
6.9222 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SRC, XDH |
6.91375 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SLC1A1, SRC, XDH |
6.90558 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, F2, HTR2A, HTR2B, KDR, MIF, SRC |
6.85819 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, FABP4, GRIK5, GRM1, GRM5, HTR2A, HTR2B, MET |
6.83435 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, EGFR, ERBB2, ESR1, FLT3, HTR1A, MET, MIF, PIM1, PRKCD, SRC, TYR |
6.78268 |
[BP] GO:0006939 |
None
|
ADRA1A, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
6.68807 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, MIF, PPARA |
6.57266 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FUT7, HTR2B, MIF, PIM1, PPARA, TYR, XDH |
6.56879 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, GRM5, HTR5A, IGF1R, MMP2, PPARA, PRKCD, SRC |
6.55602 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.54081 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRB1, DRD1, DRD2, EGFR, ERBB2, ESRRB, F2, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MIF, MMP9, PRKCD, SRC, XDH |
6.52408 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRB1, DRD1, DRD2, EGFR, ERBB2, ESRRB, F2, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MIF, MMP9, PRKCD, SRC, XDH |
6.52408 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CACNA1C, CHRM1, CHRM2, CHRM3, DRD2, EGFR, HTR2A, SLC1A1 |
6.49971 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PRKCD, SIGMAR1, SRC, TYR |
6.40257 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, ADRB1, CACNA1C, DRD1, DRD2, DRD3, EGFR, GRM5, HTR2B, HTR5A, KDR |
6.29543 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.11615 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, CA3, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HTR2A, HTR2B, KDR, PRKCD, SRC |
6.09537 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA2, CA3, CA6, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, F2, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MIF, MMP2, MMP9, PPARA, PRKCD, SRC, TYR |
6.04547 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, CA2, CA7, CACNA1C, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, F3, GRIK5, GRM5, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PPARA, PRKCD, SRC |
5.84739 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, GRM1, GRM5, HTR2A, HTR2B |
5.84554 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESRRA, F2, F3, FABP4, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MET, MIF, MMP2, MMP9, PRKCD, SRC, XDH |
5.82079 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.71404 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HSD17B1, HSD17B2, HTR1A, HTR2A |
5.62569 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, F3, GRM1, HTR2A, HTR2B, KDR, MET, MIF, MMP9, PIM1, PRKCD, SLC1A1, SRC, XDH |
5.61982 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, HTR2A, HTR2B, PRKCD, SRC |
5.55013 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, CA2, CA7, CACNA1C, CHRM1, DRD1, DRD2, DRD3, F2, GRM5, HTR1A, HTR2A, MIF, MMP9, PRKCD |
5.54667 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CACNA1C, CHRM1, CHRM2, CHRM3, DRD2, DRD3, EGFR, GRM1, HTR2A, SLC1A1 |
5.53486 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PRKCD, SRC |
5.47128 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, DRD3, F2, FABP3, FLT3, HTR2A, HTR2B, PPARA, PRKCD, SRC |
5.42862 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FLT3, HTR5A, SRC, TYR |
5.38645 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM1, CHRM3, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PRKCD |
5.35749 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
5.31039 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM1, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, F2, FABP3, GRIA2, GRIA4, GRIK5, HTR2A, HTR2B, MIF, MMP9, PPARA, PRKCD, SIGMAR1, SLC1A1, SRC, XDH |
5.30829 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.29009 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
5.2746 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, HTR2A, HTR2B, PPARA, PRKCD, SRC |
5.26322 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PRKCD, SRC |
5.25255 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HTR5A, PPARA, PRKCD, SRC |
5.1427 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM1, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, GRIA2, GRIA4, GRIK5, HTR2A, HTR2B, MIF, MMP9, PPARA, PRKCD, SIGMAR1, SLC1A1, SRC, XDH |
5.1087 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM1, CHRM3, CHRM5, DRD1, DRD2, DRD3, F2, FABP3, GRIA2, GRIA4, GRIK5, HTR2A, HTR2B, MIF, MMP9, PPARA, PRKCD, SIGMAR1, SLC1A1, SRC, XDH |
5.10556 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, DRD2, EGFR, ERBB2, ESRRB, F2, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MIF, MMP9, PRKCD, SRC, XDH |
5.09386 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
5.07497 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
5.0603 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, AXL, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, FLT3, HSD17B2, HTR5A, KDR, MMP9, PIM1, PPARA, SIGMAR1, SRC, TYR |
5.0603 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SIGMAR1, SRC, XDH |
5.05135 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, DRD1, DRD2, EGFR, ERBB2, ESRRB, F2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MIF, MMP9, PPARA, PRKCD, SRC, XDH |
5.04318 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
5.0153 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
5.0153 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, ADRB1, AKR1B1, CHRM1, CHRM3, CHRM5, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR7, SRC, TYR |
4.97433 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PRKCD, SIGMAR1, SRC, XDH |
4.97433 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SIGMAR1, SLC1A1, SRC, TYR, XDH |
4.93955 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
4.89697 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
4.85782 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.84157 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, IGF1R, MIF, PRKCD, SRC |
4.82629 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, KDR, MIF, SRC, XDH |
4.81566 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HTR2A, HTR2B, IGF1R, MIF, MMP9, PRKCD, SRC, XDH |
4.80995 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, CA2, CA7, CACNA1C, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, GRIK5, GRM5, HTR1A, HTR2A, HTR2B, MIF, MMP9, PPARA, PRKCD, SRC |
4.74775 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, CA1, CSNK2A1, DRD2, EGFR, ERBB2, F2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP2, MMP9, PRKCD, SRC |
4.73616 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, IGF1R, KDR, MIF, PRKCD, SRC, XDH |
4.73242 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, HTR5A, SRC, TYR |
4.71189 |
[BP] GO:0001659 |
None
|
ADORA1, ADRB1, DRD1, DRD2, HTR2A |
4.71171 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, DRD2, EGFR, ERBB2, F2, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MIF, MMP9, PRKCD, SRC, XDH |
4.68336 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, ADRB1, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HTR2A, HTR2B, IGF1R, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SRC, XDH |
4.66499 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, ERBB2, F3, MET, SRC, XDH |
4.66367 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.65306 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
4.65098 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
4.59112 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.59112 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.56435 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.52418 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, DRD2, EGFR, ERBB2, F2, FLT3, GRM1, GRM5, HTR2A, HTR2B, MIF, PRKCD, SRC |
4.5137 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.50391 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.50391 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, PRKCD, SRC |
4.50391 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.4786 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2, GRIK5, GRM1, GRM5, HTR2A, HTR2B |
4.47409 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, HTR2B, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, SIGMAR1, SRC, XDH |
4.45851 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.42257 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, DRD1, DRD2, EGFR, ERBB2, F2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MIF, MMP9, PRKCD, SRC, XDH |
4.41181 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
4.40628 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ADRB1, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PPARA, PRKCD, SRC, XDH |
4.3908 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, GRM1, HTR2A, HTR2B, MMP2, PPARA, SRC, TYR |
4.38444 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
4.3802 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, ADRB1, AKR1B1, AXL, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, GRM5, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, MIF, PRKCD, SRC |
4.37355 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRB1, AXL, CA2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F2, F3, HTR2A, HTR2B, KDR, MET, MIF, MMP9, PIM1, SLC1A1, SRC |
4.34464 |
[BP] GO:1900542 |
None
|
ADRB1, DRD1, DRD2, DRD3, ESRRB, GRM3, GRM8, HTR2A, PPARA |
4.34464 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
4.34224 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F2, F3, FABP4, KDR, MET, MIF, PPARA, PRKCD |
4.32846 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.32153 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
4.30133 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, DRD1, DRD2, HTR2A, MET |
4.28706 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
4.28358 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, DRD2, EGFR, ERBB2, F2, FLT3, GRM1, GRM5, HTR2A, HTR2B, MIF, PRKCD, SRC |
4.26962 |
[BP] GO:0006140 |
None
|
ADRB1, DRD1, DRD2, DRD3, ESRRB, GRM3, GRM8, HTR2A, PPARA |
4.25844 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
4.25844 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, EGFR |
4.22422 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CA3, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, PRKCD, SRC |
4.22004 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DRD2, EGFR, ERBB2, F2, PPARA |
4.20038 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, HSD17B1, HSD17B2 |
4.1797 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, ESR1, F2, GRM1, HTR2A, HTR2B |
4.16723 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, DRD2, DRD3, PPARA |
4.13772 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
4.1371 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.10711 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, ADRB1, AURKB, DRD2, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, MET, MIF, MMP9, PRKCD, SRC, XDH |
4.09828 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
4.09795 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ADRB1, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PPARA, PRKCD, SRC, XDH |
4.09731 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRIK5, HTR1A, SLC1A1 |
4.08565 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, DRD2, EGFR, ERBB2, FLT3, GRM1, GRM5, HTR2A, HTR2B, MIF, PRKCD, SRC |
4.05248 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SRC |
4.03575 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MIF, MMP1, MMP9, PRKCD, SRC |
4.02972 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF, PRKCD |
4.02907 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, MIF, SRC |
3.97455 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, HTR2B, MIF, PRKCD, SRC |
3.97455 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, EGFR, ERBB2, FABP3, FABP4, FUT7, MET, MIF, PPARA |
3.97067 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.96618 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, DRD2, EGFR, ERBB2, F2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, MIF, PRKCD, SRC |
3.95587 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, EGFR, HTR2A, HTR2B, KDR, MIF, SRC |
3.93418 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, EGFR, ERBB2, HTR2A, HTR2B, KDR, MIF, SRC |
3.85315 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.84387 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PRKCD, SRC |
3.84207 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
3.82261 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PRKCD, SRC, TYR |
3.80421 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, F2, MIF, PPARA, PRKCD |
3.80421 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, F2, F3, FABP4, FLT3, GRM1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MIF, MMP2, MMP9, PPARA, PRKCD, SRC, XDH |
3.80421 |
[BP] GO:0019933 |
None
|
ADRA1A, ADRB1, DRD1, DRD2, DRD3, HTR5A |
3.79926 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ADRB1, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PPARA, PRKCD, SRC, XDH |
3.78352 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, HTR7, PPARA, SRC |
3.74975 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.74283 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.74283 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.7404 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, DRD2, EGFR, ERBB2, F2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, MIF, PRKCD, SRC |
3.72151 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, ADRB1, AURKB, DRD2, EGFR, ERBB2, ESR1, F2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, MIF, PRKCD, SRC, XDH |
3.69147 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, HTR2A, IGF1R, MET, MIF, MMP9, PRKCD, SRC, XDH |
3.69147 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MET, MIF, MMP1, MMP9, PRKCD, SRC |
3.67953 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.67953 |
[BP] GO:0007202 |
None
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.67953 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, HTR2A, IGF1R, MET, MIF, MMP9, PRKCD, SRC, XDH |
3.67953 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2, GRIK5, GRM1, GRM5, HTR2A, HTR2B |
3.66577 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF |
3.66568 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SIGMAR1, SLC1A1, SRC, XDH |
3.65448 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, DRD2, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, MIF, PRKCD, SRC |
3.65183 |
[BP] GO:0030817 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
3.64488 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PRKCD, SRC |
3.62447 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CACNA1C, CYP19A1, DRD2, DRD3, EGFR, GRIK5, HTR1A, HTR2A, HTR2B, MIF, SRC |
3.62166 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GRM3, GRM8, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SRC, XDH |
3.60376 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MIF, MMP1, MMP9, PRKCD, SRC |
3.60222 |
[BP] GO:0019935 |
None
|
ADRA1A, ADRB1, DRD1, DRD2, DRD3, HTR5A |
3.60222 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, F2 |
3.55513 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2, GRM1, GRM5, HTR2A, HTR2B |
3.54704 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.54704 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.54704 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CACNA1C, CHRM1, DRD2, DRD3, EGFR, ERBB2, F2, HTR2B, MIF, PRKCD, SRC |
3.52959 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF |
3.51636 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.51145 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, CSNK2A1, DRD2, EGFR, ERBB2, ESR1, F2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MIF, MMP9, PRKCD, SRC, XDH |
3.50588 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.50481 |
[BP] GO:0050730 |
None
|
ADORA1, EGFR, FLT3, GRM5, HTR2A, MIF, PRKCD, SRC |
3.50479 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PRKCD, SRC, TYR |
3.48593 |
[BP] GO:0019229 |
None
|
ADRA1A, CHRM1, CHRM3, EGFR, HTR2A |
3.48316 |
[BP] GO:0042391 |
None
|
ADORA1, ADRA1A, CACNA1C, DRD1, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.47882 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, CHRM1, CHRM3, DRD2, F2, F3, MET, PRKCD, XDH |
3.47882 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ERBB2, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, PRKCD, SRC |
3.46703 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, IGF1R, MET, MIF, MMP9, PPARA, PRKCD, SRC, XDH |
3.46437 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, DRD2, EGFR, ERBB2, F2, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MIF, MMP9, PRKCD, SRC, XDH |
3.45824 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PPARA, PRKCD, SRC, XDH |
3.44661 |
[BP] GO:0008016 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CACNA1C, CHRM2, DRD2, SLC1A1 |
3.43704 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, IGF1R, MIF, PRKCD, SRC |
3.42945 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.42945 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, DRD1, EGFR, ERBB2, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, PRKCD, SRC |
3.42945 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MIF, MMP9, PRKCD, SRC, XDH |
3.42292 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.41236 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PRKCD, SRC |
3.38672 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.37027 |
[BP] GO:0060402 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
3.37027 |
[BP] GO:0051282 |
None
|
CACNA1C, DRD1, DRD2, F2, HTR2A, HTR2B |
3.34833 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, PRKCD, SRC |
3.34288 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM3 |
3.34288 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CACNA1C, CYP19A1, DRD2, DRD3, EGFR, GRIK5, HTR1A, HTR2A, HTR2B, MIF, SRC |
3.33916 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, ESR1, IGF1R, MET, MIF, MMP9, PRKCD, SRC, XDH |
3.33844 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.33197 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HTR2B, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, SRC |
3.32436 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, DRD2, EGFR, ERBB2, ESR1, F2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MIF, MMP9, PRKCD, SRC, XDH |
3.31045 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
ERBB2, HTR2A, HTR2B, IGF1R |
3.30292 |
[BP] GO:0030814 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
3.29598 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.2826 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.2826 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA1, CA2, CA7, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SIGMAR1, SLC1A1, SRC, XDH |
3.27057 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR |
3.26524 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.25495 |
[BP] GO:0030802 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
3.24077 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
3.23776 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, PRKCD, SRC |
3.23555 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CA1, CA2, CA7, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SIGMAR1, SRC, XDH |
3.23474 |
[BP] GO:1903524 |
None
|
ADRA1A, ADRB1, EGFR, HTR2A, SLC1A1 |
3.20986 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, GRM3, GRM8, PPARA |
3.1837 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.16402 |
[BP] GO:0007189 |
None
|
ADRA1A, ADRB1, DRD1, DRD2, DRD3 |
3.15796 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, GRM3, GRM8, PPARA |
3.15796 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
3.15295 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SRC, TYR, XDH |
3.13894 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, MIF, SRC |
3.13894 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, PRKCD, SRC |
3.07785 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GRM3, GRM8, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SRC, XDH |
3.07535 |
[BP] GO:0050890 |
None
|
ADORA1, CHRM1, DRD1, DRD2, DRD3, EGFR, GRM5, HTR2A |
3.06757 |
[BP] GO:1900371 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
3.06757 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.05892 |
[BP] GO:0060401 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
3.05892 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.05509 |
[BP] GO:0030808 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
3.05509 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.03509 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, DRD1, DRD2, EGFR, ERBB2, F2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MIF, MMP9, PRKCD, SRC, XDH |
3.02238 |
[BP] GO:0001997 |
None
|
ADRA1A, ADRB1 |
2.98899 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.98899 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, PRKCD, SRC |
2.96975 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.9624 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.9624 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.9624 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PRKCD, SRC |
2.93834 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, CHRM1, DRD2, EGFR, ERBB2, F2, HTR2B, MIF, PRKCD, SRC |
2.88141 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HTR2B, MIF, SRC |
2.87897 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.86782 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.86782 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.86782 |
[BP] GO:0030799 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
2.86026 |
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
2.85009 |
[BP] GO:0006936 |
None
|
ADRA1A, CHRM3, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.84031 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, MIF, PPARA |
2.83901 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, HTR2B, MIF, SRC |
2.83213 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.80285 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.80285 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.78456 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MIF, MMP1, MMP2, PIM1, PPARA, PRKCD, SRC, TYR, XDH |
2.77664 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.76675 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.76675 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.76675 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, ADRB1, DRD2, DRD3, PPARA |
2.75946 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, GRIK5, HTR1A |
2.74569 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, MET, SRC |
2.71433 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.71007 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.71007 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.71007 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.70229 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF |
2.67494 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.6685 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, CHRM1, DRD2, EGFR, ERBB2, F2, HTR2B, MIF, PRKCD, SRC |
2.66691 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
2.64332 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.63552 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, ERBB2, F2, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.62384 |
[BP] GO:0002027 |
None
|
ADRA1A, ADRB1, CACNA1C, DRD2, SLC1A1 |
2.60654 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.60447 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.60447 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA1A, CACNA1C, CHRM1, CHRM2, CHRM3 |
2.59301 |
[BP] GO:0043270 |
None
|
ADORA1, CHRM1, DRD1, DRD2, F2, MIF, PRKCD |
2.58279 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.57939 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.57939 |
[BP] GO:0001996 |
None
|
ADRA1A, ADRB1 |
2.57939 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.57939 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.57939 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.57939 |
[BP] GO:0003099 |
None
|
ADRA1A, ADRB1 |
2.57939 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.57435 |
[BP] GO:0050877 |
None
|
ADORA1, CHRM1, CHRM5, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, GRM8, HTR2A, TYR |
2.5654 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HTR2A, MET, SRC |
2.54266 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HTR2A, MET, SRC |
2.54266 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HTR2A, MET, SRC |
2.54266 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HTR2A, MET, SRC |
2.54266 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, MET, PPARA, PRKCD, SRC |
2.52502 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.52452 |
[BP] GO:0007610 |
None
|
DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, HTR1A, HTR2A, HTR2B, PPARA |
2.52408 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.51524 |
[BP] GO:0046903 |
None
|
ALOX5, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, DRD2, DRD3, MIF, MMP9, PRKCD, SLC1A1, XDH |
2.49924 |
[BP] GO:0051223 |
None
|
ACHE, CACNA1C, CHRM1, DRD2, DRD3, EGFR, ERBB2, F2, HTR2B, MIF, PRKCD, SRC |
2.49232 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, F2, PPARA, PRKCD |
2.47711 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.46917 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, CA3, CYP1B1, EGFR, MMP9, PRKCD, SRC |
2.45446 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.45446 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRB1, DRD2 |
2.45446 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, HTR2A, MIF, SRC |
2.4544 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.44444 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
2.44444 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ERBB2, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MIF, MMP2, MMP9, PRKCD, SRC |
2.44009 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HTR2B, MIF, SRC |
2.43317 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD, SRC |
2.42937 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AURKB, CA9, CHRM5, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SRC, XDH |
2.413 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CACNA1C, DRD2, DRD3, EGFR, HTR2B, MIF, SRC |
2.40232 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.40232 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.40232 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, DRD1, EGFR, ERBB2, ESR1, FLT3, GRM5, IGF1R, MMP2, PRKCD, SRC |
2.38241 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CACNA1C, CYP19A1, DRD2, EGFR, HTR1A, HTR2A |
2.35846 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM5, DRD1, DRD2, DRD3, FABP3, PPARA, SIGMAR1, SLC1A1 |
2.35826 |
[BP] GO:0019722 |
calcium-mediated signaling
|
CACNA1C, EGFR, GRM5, HTR2B, KDR |
2.34524 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.345 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.32714 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.32714 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.32714 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
AXL, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F2, FUT7, HTR2B, HTR6, KDR, MIF, MMP1, MMP9, PRKCD, SRC |
2.31965 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, F2, PPARA, PRKCD |
2.31721 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AURKB, CA9, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SRC, XDH |
2.31581 |
[BP] GO:0070201 |
None
|
ACHE, CACNA1C, CHRM1, DRD2, DRD3, EGFR, ERBB2, F2, HTR2B, MIF, PRKCD, SRC |
2.31051 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.29664 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.29664 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD |
2.29664 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.29664 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
ERBB2, HTR2A, HTR2B, IGF1R |
2.29664 |
[BP] GO:0010460 |
None
|
ADRA1A, ADRB1, SLC1A1 |
2.24669 |
[BP] GO:0071875 |
None
|
ADRA1A, ADRB1, DRD2 |
2.24669 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.24669 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, PRKCD |
2.24269 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F2, F3, FABP4, KDR, MET, MIF |
2.22384 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, PRKCD |
2.22384 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
ERBB2, HTR2A, HTR2B, IGF1R |
2.22384 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRB1, AURKB, CA9, CHRM5, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SRC, XDH |
2.2123 |
[BP] GO:0022600 |
None
|
CHRM1, CHRM3, CHRM5, DRD3 |
2.20045 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, HTR5A |
2.18335 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
2.16886 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.15479 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.15479 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.15479 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, F2, FABP4, PPARA, PRKCD |
2.14202 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.14202 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.14202 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.14202 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.14202 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.14202 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.14202 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.14202 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, SRC |
2.14012 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.11696 |
[BP] GO:0045745 |
None
|
DRD2, DRD3, F2 |
2.11696 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, MET, MMP9, PPARA, PRKCD, SRC |
2.11268 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PRKCD, SRC |
2.11075 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, DRD1, EGFR, GRM5, IGF1R, MMP2, PRKCD, SRC |
2.09766 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, F2, F3, FABP4, IGF1R, MET, MIF, MMP2, PPARA, PRKCD, SRC, XDH |
2.08301 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, DRD1, PRKCD |
2.07625 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.07625 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.07625 |
[BP] GO:0060341 |
regulation of cellular localization
|
CACNA1C, CHRM1, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, GRIK5, PRKCD, SRC |
2.07356 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, CACNA1C, CHRM1, CSNK2A1, DRD2, DRD3, EGFR, ERBB2, F2, HTR2B, MIF, PRKCD, SRC |
2.04351 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, CSNK2A1, DRD2, EGFR, ERBB2, FABP3, FABP4, MET |
2.03904 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, HTR7, PPARA |
2.02517 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2, TYR, XDH |
2.02041 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MIF, MMP9, PRKCD, SRC, XDH |
2.00034 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC1A1 |
11.7286 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC1A1, SRC |
11.6084 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, MET, SIGMAR1, SLC1A1, SRC |
10.5825 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC1A1 |
10.5547 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PRKCD, SLC1A1, SRC |
9.39142 |
[CC] GO:0097060 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SIGMAR1 |
6.47471 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SIGMAR1, SRC |
6.44207 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, ALOX5, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PRKCD, SIGMAR1, SLC1A1, SRC, TYR |
6.21077 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC1A1, SRC, TYR |
6.04547 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, CHRM1, DRD2, GRIK5, GRM1, GRM3, GRM5, SIGMAR1, SRC |
5.89334 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, CHRM1, DRD2, GRIK5, GRM1, GRM3, GRM5, SIGMAR1, SRC |
5.89334 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, SRC |
4.93955 |
[CC] GO:0045211 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM3, SIGMAR1 |
4.66367 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, SRC |
4.39167 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA12, CA14, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC1A1, TYR |
4.33324 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, SRC |
4.1497 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CA12, CA14, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC1A1, TYR |
3.83321 |
[CC] GO:0097458 |
None
|
ADORA1, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, HTR5A, SIGMAR1, SRC |
3.77869 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, HTR2A, SIGMAR1, SRC |
3.54044 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, HTR2A, SIGMAR1, SRC |
3.54044 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.42945 |
[CC] GO:0045202 |
None
|
ACHE, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, GRIA2, HTR2B |
3.19146 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, CHRM3, EGFR, ERBB2 |
3.1837 |
[CC] GO:0098793 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, DRD2, GRIK5 |
2.53685 |
[CC] GO:0030425 |
None
|
CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIK5, GRM1, HTR5A |
2.52408 |
[CC] GO:0043679 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.44444 |
[CC] GO:0043197 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.27225 |
[CC] GO:0044309 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.24269 |
[CC] GO:0044306 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.09766 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
19.9373 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1 |
19.9373 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
19.7273 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1 |
18.312 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1 |
17.9116 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1 |
16.9548 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
15.9888 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
15.5078 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
15.5078 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.538 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
12.4882 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, TYR, XDH |
12.4571 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.0993 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SLC1A1, SRC, TYR, XDH |
10.5825 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRM3, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
9.71858 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
9.01508 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.38317 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SLC1A1, TYR, XDH |
8.19151 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PRKCD, SIGMAR1, SRC |
7.87845 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
7.26279 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.9222 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.9222 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.9222 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.9222 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.54081 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, CHRM3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.47895 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA |
6.29543 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.97641 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.30019 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.30019 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR, ERBB2, F2, F3, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIM1, PRKCD, SRC, TYR, XDH |
5.17392 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
5.1427 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.0603 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, XDH |
4.50391 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.13201 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.00984 |
[MF] GO:1901338 |
None
|
ADRB1, DRD1, DRD2, DRD3 |
3.96618 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.84387 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.84387 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
3.70435 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.51145 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.41236 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.34833 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F2, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SLC1A1, TYR, XDH |
3.23952 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCD, SRC |
3.15745 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC |
3.08148 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.05892 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.98899 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.9624 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC |
2.92302 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, EGFR, HSD17B1, IGF1R |
2.85009 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
2.83038 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2, TYR, XDH |
2.74488 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRB1, DRD2 |
2.71007 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
2.67494 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.57939 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.51524 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.51524 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCD, SRC |
2.48278 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.42937 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, HSD17B1, PPARA |
2.41709 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.32714 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.32714 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, SRC, XDH |
2.21433 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP9, PIM1, PPARA, SRC |
2.18978 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCD, SRC |
2.17 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.14202 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.11696 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, CSNK2A1, DRD2, EGFR, ERBB2, ESR1, ESR2, FLT3, GRIK5, IGF1R, KDR, MET, MIF, MMP9, TYR, XDH |
2.06798 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, HSD17B1, HSD17B2, XDH |
2.02517 |